Hyderabad based Graviti Pharma has entered the Karnataka market, marking a key step in its India expansion strategy focused on quality driven, globally compliant pharmaceutical growth.
Glimpse:
Graviti Pharma has launched its operations in Karnataka as part of its broader India growth plan. The company, known for its USFDA aligned manufacturing and strong presence in global markets, aims to strengthen its domestic footprint and scale its high quality pharmaceutical platform across key regions.
Hyderabad headquartered Graviti Pharmaceuticals has officially launched its operations in Karnataka, signaling a major milestone in its expansion across India. The move builds on the company’s existing presence in Andhra Pradesh and Telangana and represents the next phase of its strategic growth journey in the domestic market.
Founded in 2012, Graviti Pharma specializes in developing complex and modified release generic medicines, with a strong foothold in regulated international markets such as the United States. The company operates a USFDA aligned manufacturing facility in Pashamylaram, Hyderabad, with the capacity to produce billions of tablets annually, reinforcing its focus on global quality standards and compliance.
India’s pharmaceutical sector, valued at over $50 billion, is witnessing increasing demand for complex generics, especially in highly regulated markets. Graviti’s expansion into Karnataka aligns with this industry trend, as it aims to strengthen its presence in key domestic regions while maintaining a global outlook.
Company leadership emphasized that the Karnataka entry is part of a long term plan to build a scalable and quality focused pharmaceutical platform across India. With a strong foundation in international markets and a compliance driven approach, the company is positioning itself as a competitive player in both domestic and global pharma segments.
The expansion also reflects Graviti Pharma’s commitment to operational efficiency and geographic diversification, as it continues to grow under the leadership of Managing Director Dheeraj Gorukanti and COO Thilak Vangala.
“Our entry into Karnataka represents a strategic milestone in our India growth journey.”
By
HB Team
